Amrysin Capsules

Indication

Management of neuropathic pain, generalized anxiety disorder, and as an adjunctive therapy for partial seizures.

Dosage (summary)

Initial dose of 150 mg/day, which may be increased to a maximum of 600 mg/day based on clinical response.

Onset of Action / Duration

Analgesic effects may be observed within 1 week; maximum effect may take several weeks.

Special Populations

• Elderly patients
• Patients with renal impairment
• Patients with hepatic impairment

Pregnancy & Breastfeeding

Pregabalin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk; caution is advised when administered to nursing mothers.

Key Drug Interactions

• CNS depressants (e.g., opioids, benzodiazepines) may enhance sedative effects.
• Antidiabetic medications may require monitoring as Pregabalin can cause weight gain.

Contraindications

• Hypersensitivity to Pregabalin or any of its components
• Severe renal impairment (CrCl < 30 mL/min) without dose adjustment

Common side effects

• Dizziness
• Somnolence
• Dry mouth
• Edema
• Weight gain
• Blurred vision

Counselling Points

• Advise patients to avoid abrupt discontinuation to prevent withdrawal symptoms.
• Inform patients about the potential for dizziness and sedation; caution when driving or operating machinery.
• Encourage patients to report any signs of mood changes or suicidal thoughts.